Abiopharma

🔍 Hazelton Joseph P (Executive)

Company: DYADIC INTERNATIONAL INC (DYAI)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 36,418 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 191,758.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 67,250 shares of Stock Option at $0.94 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 67,250.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: Represents common stock issued upon the vesting of RSUs. The RSUs were granted pursuant to the Issuer's key employee annual bonus, in lieu of a cash bonus earned for the year ended 2025. The RSUs vested in full upon grant.
• F2: Annual grant of stock options.
• F3: This option vests in four equal installments beginning on the first anniversary of the date of grant, subject to continued service to the Issuer.